300 related articles for article (PubMed ID: 29358037)
1. Antidepressant-Induced Activation in Children and Adolescents: Risk, Recognition and Management.
Luft MJ; Lamy M; DelBello MP; McNamara RK; Strawn JR
Curr Probl Pediatr Adolesc Health Care; 2018 Feb; 48(2):50-62. PubMed ID: 29358037
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis.
Strawn JR; Welge JA; Wehry AM; Keeshin B; Rynn MA
Depress Anxiety; 2015 Mar; 32(3):149-57. PubMed ID: 25449861
[TBL] [Abstract][Full Text] [Related]
3. Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents.
Strawn JR; Mills JA; Poweleit EA; Ramsey LB; Croarkin PE
Pharmacotherapy; 2023 Jul; 43(7):675-690. PubMed ID: 36651686
[TBL] [Abstract][Full Text] [Related]
4. Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety.
Strawn JR; Dobson ET; Giles LL
Curr Probl Pediatr Adolesc Health Care; 2017 Jan; 47(1):3-14. PubMed ID: 28043839
[TBL] [Abstract][Full Text] [Related]
5. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of antidepressant drug treatment in children and adolescents.
Henry A; Kisicki MD; Varley C
Mol Psychiatry; 2012 Dec; 17(12):1186-93. PubMed ID: 22064376
[TBL] [Abstract][Full Text] [Related]
7. [Selective serotonin and noradrenaline reuptake inhibitors: a step forward in the treatment of depression?].
Möller HJ; Bauer M; Fritze J; Haen E; Laux G; Müller WE; Rüther E
MMW Fortschr Med; 2005 Jan; 147(3):43-5. PubMed ID: 15727113
[TBL] [Abstract][Full Text] [Related]
8. New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Hetrick SE; McKenzie JE; Bailey AP; Sharma V; Moller CI; Badcock PB; Cox GR; Merry SN; Meader N
Cochrane Database Syst Rev; 2021 May; 5(5):CD013674. PubMed ID: 34029378
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Hetrick S; Merry S; McKenzie J; Sindahl P; Proctor M
Cochrane Database Syst Rev; 2007 Jul; (3):CD004851. PubMed ID: 17636776
[TBL] [Abstract][Full Text] [Related]
10. A systematic review on the genotoxic effect of serotonin and norepinephrine reuptake inhibitors (SNRIs) antidepressants.
Ahmadimanesh M; Balarastaghi S; Rashedinia M; Yazdian-Robati R
Psychopharmacology (Berl); 2020 Jul; 237(7):1909-1915. PubMed ID: 32529266
[TBL] [Abstract][Full Text] [Related]
11. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy in depressed children and adolescents.
Taurines R; Gerlach M; Warnke A; Thome J; Wewetzer C
World J Biol Psychiatry; 2011 Sep; 12 Suppl 1():11-5. PubMed ID: 21905988
[TBL] [Abstract][Full Text] [Related]
13. Antidepressant-induced jitteriness/anxiety syndrome: systematic review.
Sinclair LI; Christmas DM; Hood SD; Potokar JP; Robertson A; Isaac A; Srivastava S; Nutt DJ; Davies SJ
Br J Psychiatry; 2009 Jun; 194(6):483-90. PubMed ID: 19478285
[TBL] [Abstract][Full Text] [Related]
14. [The use of antidepressants to treat depression in children and adolescents].
Desombre H; Paccalin C; Revol O; Fourneret P
Arch Pediatr; 2006 Jun; 13(6):711-3. PubMed ID: 16697608
[No Abstract] [Full Text] [Related]
15. Serotonin-norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: a new-user cohort study among US adults aged 50 years and older.
Lanteigne A; Sheu YH; Stürmer T; Pate V; Azrael D; Swanson SA; Miller M
CNS Drugs; 2015 Mar; 29(3):245-52. PubMed ID: 25708711
[TBL] [Abstract][Full Text] [Related]
16. Adolescent angst or true intent? Suicidal behavior, risk, and neurobiological mechanisms in depressed children and teenagers taking antidepressants.
Morrison J; Schwartz TL
Int J Emerg Ment Health; 2014; 16(1):247-50. PubMed ID: 25345238
[TBL] [Abstract][Full Text] [Related]
17. Antidepressants for people with epilepsy and depression.
Maguire MJ; Marson AG; Nevitt SJ
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
[TBL] [Abstract][Full Text] [Related]
18. Agomelatine versus other antidepressive agents for major depression.
Guaiana G; Gupta S; Chiodo D; Davies SJ; Haederle K; Koesters M
Cochrane Database Syst Rev; 2013 Dec; (12):CD008851. PubMed ID: 24343836
[TBL] [Abstract][Full Text] [Related]
19. Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults.
Sobieraj DM; Martinez BK; Hernandez AV; Coleman CI; Ross JS; Berg KM; Steffens DC; Baker WL
J Am Geriatr Soc; 2019 Aug; 67(8):1571-1581. PubMed ID: 31140587
[TBL] [Abstract][Full Text] [Related]
20. Attention-deficit/hyperactivity disorder in children following prenatal exposure to antidepressants: results from the Norwegian mother, father and child cohort study.
Lupattelli A; Mahic M; Handal M; Ystrom E; Reichborn-Kjennerud T; Nordeng H
BJOG; 2021 Nov; 128(12):1917-1927. PubMed ID: 33982858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
